Form 8-K Spectrum Brands Holdings For: Nov 04
http://archive.fast-edgar.com/20261104/AW2J4Q22ZC22RZWZ25232Z423UWAZK22Z282
Filed on: November 4, 2026
Form 8-K Madison Square Garden For: Nov 04
http://archive.fast-edgar.com/20261104/ARZ7UG2COZ22TZ2Z2WTD2ZZ2VVA3Z22IZ282
Filed on: November 4, 2026
Form 8-K Royalty Pharma plc For: Nov 04
FALSE000180276800018027682026-11-042026-11-04UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 OR 15(d)of The Securities Exchange Act of 1934Date of Report (Date of earliest event reported): November 4, 2026Royalty Pharma plc(Exact Name of Registrant as Specified in its Charter)England and Wales001-3932998-1535773(State or other jurisdictionof incorporation)(CommissionFile Number)(I.R.S.Identification No.)... (continue reading...)
Form 8-K NewAmsterdam Pharma Co For: Nov 04
false000193625800-00000000001936258us-gaap:CommonStockMember2026-11-042026-11-0400019362582026-11-042026-11-040001936258us-gaap:WarrantMember2026-11-042026-11-04
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 4, 2026
NewAmsterdam Pharma Company... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K Fidelity National Inform For: Nov 04
-
Form 8-K FOSTER L B CO For: Nov 02
-
Form 8-K Medline Inc. For: Nov 04
-
Form 8-K SCOTTS MIRACLE-GRO CO For: Nov 04
-
Form 8-K NCR Atleos Corp For: Nov 04
-
Form 10-Q VISHAY INTERTECHNOLOGY For: Oct 03
-
Form 10-Q Latham Group, Inc. For: Sep 26
-
Form 8-K Riot Platforms, Inc. For: Oct 29
-
Form 10-Q Dine Brands Global, Inc. For: Sep 27
-
Form 8-K WESTLAKE CORP For: Nov 04
-
Form 8-K Westlake Chemical Partne For: Nov 04
-
Form 6-K JD.com, Inc. For: Nov 04
-
Form 10-Q Rapport Therapeutics, For: Sep 30
-
Form 8-K Polar Power, Inc. For: Nov 04
-
Form 8-K Tronox Holdings plc For: Nov 03
-
Form 10-Q Viridian Therapeutics, For: Sep 30
-
Form 8-K ARROWHEAD PHARMACEUTICAL For: Nov 04
-
Form 6-K dLocal Ltd For: Nov 04
-
Form 4 Seaport Therapeutics, For: Nov 03 Filed by: Torres Denice
-
Form 6-K Itau Unibanco Holding For: Nov 03
-
Form 10-Q uniQure N.V. For: Sep 30
-
Form 4 Estrella Immunopharma, For: Nov 02 Filed by: Pussinen Cynthia
-
Form 8-K NATURAL RESOURCE PARTNER For: Nov 04
-
Form 8-K CS Disco, Inc. For: Nov 04
-
Form 8-K VISHAY INTERTECHNOLOGY For: Nov 04
-
Form 10-Q Shoals Technologies Grou For: Sep 30
-
Form 6-K GLOBALFOUNDRIES Inc. For: Sep 30
-
Form 8-K Array Technologies, Inc. For: Nov 04
-
Form 8-K Kyndryl Holdings, Inc. For: Nov 04
-
Form 10-Q Odyssey Therapeutics, For: Sep 30
-
Form 10-Q Q32 Bio Inc. For: Sep 30
-
Form 8-K Dine Brands Global, Inc. For: Nov 04
-
Form 10-Q LIFECORE BIOMEDICAL, For: Sep 30
-
Form 8-K SelectQuote, Inc. For: Nov 04
-
Form 8-K LIFECORE BIOMEDICAL, For: Nov 04
-
Form 6-K Brookfield Renewable For: Sep 30
-
Form 10-Q FISERV INC For: Sep 30
-
Form 8-K GERON CORP For: Nov 04
-
Form 8-K Rapport Therapeutics, For: Nov 04
-
Form 8-K Datadog, Inc. For: Nov 04
-
Form 8-K Viridian Therapeutics, For: Nov 04
-
Form 10-Q MoonLake Immunotherapeut For: Sep 30
-
Form 6-K Itau Unibanco Holding For: Nov 03
-
Form 8-K uniQure N.V. For: Nov 04
-
Form 8-K Shoals Technologies Grou For: Nov 04
-
Form 10-Q Pharmaceutical Resource For: Sep 30
-
Form 6-K GLOBALFOUNDRIES Inc. For: Sep 30
-
Form 6-K Brookfield Renewable For: Sep 30
-
Form 144 Luckin Coffee Inc. Filed by: An Jing
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/


